Celera Expands Gene Expression Offerings Through Database Partnership with Lynx | GenomeWeb

Celera Genomics and Lynx Therapeutics have signed two agreements based on Lynx’s MPSS technology for gene expression analysis.

Under the first part of the multi-year agreement, Lynx’s gene expression data from normal human tissues will be integrated into the Celera Discovery System. The second part of the agreement involves additional gene expression analysis that Lynx of Hayward, Calif., will perform for Celera of Rockville, Md., to supplement the database offering.

Financial terms of the agreement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.